Literature DB >> 15973770

Extracellular HIV Tat and Tat cysteine rich peptide increase CCR5 expression in monocytes.

Lin Zheng1, Yi-da Yang, Guo-cai Lu, Maria S Salvato.   

Abstract

In our previous work we reported that HIV Tat and 6 cysteine rich peptides of Tat induce tumor necrosis factor-related apoptosis-induced ligand (TRAIL) in human monocytes (Yang et al., 2003). Here our results showed that HIV Tat and Tat cysteine rich peptide increase CCR5 expression in human monocytes, and this activity is inhibited by rabbit anti-Tat. Boiled Tat does not increase CCR5 expression in monocytes. These results provide insight into a new mechanism by which HIV Tat plays a key role in the pathogenesis of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15973770      PMCID: PMC1389802          DOI: 10.1631/jzus.2005.B0668

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  14 in total

1.  Tat-neutralizing antibodies in vaccinated macaques.

Authors:  Ilia Tikhonov; Tracy J Ruckwardt; Glen S Hatfield; C David Pauza
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

3.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

Review 4.  Tat and the HIV-1 promoter.

Authors:  K A Jones
Journal:  Curr Opin Cell Biol       Date:  1993-06       Impact factor: 8.382

5.  Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors.

Authors:  M Ott; J L Lovett; L Mueller; E Verdin
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

6.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism.

Authors:  Yida Yang; Ilia Tikhonov; Tracy J Ruckwardt; Mahmoud Djavani; Juan Carlos Zapata; C David Pauza; Maria S Salvato
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

Authors:  M O Westendorp; R Frank; C Ochsenbauer; K Stricker; J Dhein; H Walczak; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

10.  Identification of a novel domain of HIV tat involved in monocyte chemotaxis.

Authors:  A Albini; R Benelli; D Giunciuglio; T Cai; G Mariani; S Ferrini; D M Noonan
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

View more
  9 in total

Review 1.  Targeting anti-HIV drugs to the CNS.

Authors:  Kavitha S Rao; Anuja Ghorpade; Vinod Labhasetwar
Journal:  Expert Opin Drug Deliv       Date:  2009-08       Impact factor: 6.648

2.  tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Authors:  Raabya Rossenkhan; Iain J MacLeod; Theresa K Sebunya; Eduardo Castro-Nallar; Mary Fran McLane; Rosemary Musonda; Berhanu A Gashe; Vlad Novitsky; M Essex
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

3.  HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.

Authors:  Rémi Planès; Lbachir BenMohamed; Kaoutar Leghmari; Pierre Delobel; Jacques Izopet; Elmostafa Bahraoui
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

4.  HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.

Authors:  Rémi Planès; Elmostafa Bahraoui
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  Genetic Polymorphisms in the Open Reading Frame of the CCR5 gene From HIV-1 Seronegative and Seropositive Individuals From National Capital Regions of India.

Authors:  Larance Ronsard; Vikas Sood; Ashraf S Yousif; Janani Ramesh; Vijay Shankar; Jishnu Das; N Sumi; Tripti Rai; Kumaravel Mohankumar; Subhashree Sridharan; Arianna Dorschel; Vishnampettai G Ramachandran; Akhil C Banerjea
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

6.  Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications.

Authors:  Larance Ronsard; Sneh Lata; Jyotsna Singh; Vishnampettai G Ramachandran; Shukla Das; Akhil C Banerjea
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 7.  Current approaches to enhance CNS delivery of drugs across the brain barriers.

Authors:  Cui-Tao Lu; Ying-Zheng Zhao; Ho Lun Wong; Jun Cai; Lei Peng; Xin-Qiao Tian
Journal:  Int J Nanomedicine       Date:  2014-05-10

Review 8.  HIV-1 Tat: Role in Bystander Toxicity.

Authors:  David Ajasin; Eliseo A Eugenin
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

9.  Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.

Authors:  Lamya H Al-Wahaibi; Muneera S M Al-Saleem; Osama A A Ahmed; Usama A Fahmy; Nabil A Alhakamy; Basma G Eid; Ashraf B Abdel-Naim; Wael M Abdel-Mageed; Maha M AlRasheed; Gamal A Shazly
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.